Article
Structural basis of the UDP-diacylglucosamine pyrophosphohydrolase LpxH inhibition by sulfonyl piperazine antibiotics.
Proceedings of the National Academy of Sciences of the United States of America - 25 Feb 2020
Cho Jae, Lee Minhee, Cochrane C Skyler, Webster Caroline G, Fenton Benjamin A, Zhao Jinshi, Hong Jiyong, Zhou Pei
Abstract excerpt
The UDP-2,3-diacylglucosamine pyrophosphate hydrolase LpxH is an essential lipid A biosynthetic enzyme that is conserved in the majority of gram-negative bacteria. It has emerged as an attractive novel antibiotic target due to the recent discovery of an LpxH-targeting sulfonyl piperazine compound (referred to as AZ1) by AstraZeneca. However, the molecular details of AZ1 inhibition have remained unresolved,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
